Nani Neena Gupta at 66 shows fashion is ageless in effortlessly cool skirt look with eclectic necklaces

India, April 19 -- Neena Gupta, 66, shows there is no age limit when it comes to being fashionable. Neena continues to steal the spotlight with her outfits, defined by creative silhouettes and fascina... Read More

प्रयागराज व वाराणसी मंडल में मीटर रीचार्ज करने में बमरौली अव्वल

प्रयागराज, अप्रैल 19 -- प्रयागराज, पीयूष श्रीवास्तव। कभी बिजली चोरी के मामलों में सबसे आगे रहने वाला बमरौली डिवीजन अब प्रीपेड मीटर रीचार्ज में अव्वल बन गया है। विभाग की सख्ती और प्रीपेड मीटर व्यवस्था ... Read More

बैरिया बस स्टैंड के नए नामकरण का गजट प्रकाशन नहीं होना चिंताजनक

मुजफ्फरपुर, अप्रैल 19 -- मुजफ्फरपुर, वसं। अमर शहीद बैकुंठ शुक्ल स्मृति समारोह समिति की प्रबंध कार्यकारिणी की आपातकालीन बैठक रविवार को अधिवक्ता अरुण कुमार शुक्ल के आवास पर हुई। इसमें समिति के संस्थापक ... Read More

इस कंपनी की धमाकेदार ग्रोथ! 29% उछलकर Rs.4,228 करोड़ पहुंचा रेवेन्यू, तिमाही ने तोड़े रिकॉर्ड

नई दिल्ली, अप्रैल 19 -- स्वीडन की टेलीकॉम उपकरण बनाने वाली कंपनी एरिक्सन (Ericsson) के लिए भारत का बाजार तेजी से अहम होता जा रहा है। कंपनी के ताजा नतीजों के मुताबिक, जनवरी-मार्च 2026 तिमाही में इंडिया... Read More

BRTA, stakeholders meet as fuel price hike triggers push for bus, truck fare revision

Dhaka, April 19 -- The Bangladesh Road Transport Authority (BRTA) has held a meeting with stakeholders to determine how much bus and truck fares should increase following the recent fuel price hike. ... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

• ««
• «
• 10665
• 10666
• 10667
• 10668
• 10669
• 10670
• 10671
• 10672
• 10673
• 10674
• »
• »»